UNIGE document Scientific Article
previous document  unige:97117  next document
add to browser collection
Title

Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial

Authors
Natalucci, Giancarlo
Latal, Beatrice
Sick, Beate
Held, Leonhard
Bucher, Hans Ulrich
Fauchère, Jean-Claude
show hidden authors show all authors [1 - 9]
Collaboration
Published in JAMA (Journal of the American Medical Association). 2016, vol. 315, no. 19, p. 2079-85
Abstract Very preterm infants are at risk of developing encephalopathy of prematurity and long-term neurodevelopmental delay. Erythropoietin treatment is neuroprotective in animal experimental and human clinical studies.
Keywords Child DevelopmentChild, PreschoolDevelopmental Disabilities/prevention & controlDouble-Blind MethodDrug Administration ScheduleErythropoietin/administration & dosageFemaleHumansInfant, NewbornInfant, PrematureIntention to Treat AnalysisMaleNeurodevelopmental Disorders/prevention & controlNeuroprotective Agents/administration & dosageRecombinant Proteins/administration & dosageTreatment Outcome
Identifiers
PMID: 27187300
Full text
Article (Published version) (298 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group L'imagerie cérébrale (184)
Citation
(ISO format)
NATALUCCI, Giancarlo et al. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial. In: JAMA (Journal of the American Medical Association), 2016, vol. 315, n° 19, p. 2079-85. https://archive-ouverte.unige.ch/unige:97117

19 hits

0 download

Update

Deposited on : 2017-09-27

Export document
Format :
Citation style :